pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Camzyos · news · pharmadog
← back to Camzyos
News mentioning Camzyos
15
stories
6d
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
biopharma dive
14d
Braveheart pumps more life into biotech IPO market with $382M expected debut
biospace
15d
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui
fiercebiotech
15d
Cardiac drug developer Braveheart banks more than $382M in IPO
biopharma dive
15d
5 NextGen winners who went public this year (and which ones are hiring)
biospace
17d
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
biopharma dive
20d
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
biopharma dive
21d
BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays
biospace
21d
Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs
fiercebiotech
Jul 16, 26
Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immuno
biospace
Jul 15, 26
Braveheart, Attovia join next wave of biotech IPOs
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 18, 26
Kardigan extends biotech’s streak of big IPOs with $400M haul
biopharma dive
Jun 16, 26
Edgewise heart drug passes key trial test
biopharma dive
May 5, 26
Cytokinetics heart drug scores in closely watched trial
biopharma dive
